Atlas Trials

A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast Cancer

Clinical trial NCT04149444 · WITHDRAWN

Trial details

NCT number
NCT04149444
Sponsor
AHS Cancer Control Alberta
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Triple Negative Breast Cancer
Start date
2020-02-01
Primary completion
2020-06-09
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.